Max Reinhardt

Track

Insider profile

Currently holds a position at Pacira BioSciences, Inc.

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President Pacira BioSciences, Inc. June 19, 2019 -
Max Reinhardt's trades of Orthofix Medical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
36.02
Quantity 5,085
Value US$183,162
Transaction date
Proposed sale
Price
37.86
Quantity 1,099
Value US$41,613
Transaction date
Proposed sale
Price
38.99
Quantity 1,054
Value US$41,097
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-06 2026-03-05
S Sale
56,892 +30.7%
422.49
US$2,654,717 		56,892 +30.7% 422.49 US$2,654,717
2026-03-06 2026-03-04
S Sale
99,611 -24.5%
198.51
US$1,901,869 		99,611 -24.5% 198.51 US$1,901,869
2025-06-13 2025-06-11
S Sale
71,567 -40.7%
228.83
US$328,666 		71,567 -40.7% 228.83 US$328,666
2023-06-12 2023-06-12
PrS Proposed sale
5,085
36.02
US$183,162 		5,085 36.02 US$183,162
2023-06-07 2023-06-07
PrS Proposed sale
1,099
37.86
US$41,613 		1,099 37.86 US$41,613
2023-06-07 2023-06-07
S Sale
1,099 -3.6%
37.87
US$41,614 		1,099 -3.6% 37.87 US$41,614
2023-06-07 2023-06-06
S Sale
1,054 -3.4%
38.99
US$41,097 		1,054 -3.4% 38.99 US$41,097
2023-06-06 2023-06-06
PrS Proposed sale
1,054
38.99
US$41,097 		1,054 38.99 US$41,097
2022-10-11 2022-10-07
PlS Planned sale
1,380 -4.2%
58.00
US$80,040 		1,380 -4.2% 58.00 US$80,040
2022-06-08 2022-06-07
PlS Planned sale
2,433 -9.1%
62.00
US$150,846 		2,433 -9.1% 62.00 US$150,846
2022-06-08 2022-06-06
S Sale
2,817 -9.5%
61.37
US$172,891 		2,817 -9.5% 61.37 US$172,891
2022-04-25 2022-04-21
PlS Planned sale
9,824 -24.9%
73.25
US$719,647 		9,824 -24.9% 73.25 US$719,647
2022-04-20 2022-04-20
PlS Planned sale
9,764 -26.6%
73.99
US$722,438 		9,764 -26.6% 73.99 US$722,438
2022-04-20 2022-04-19
PlS Planned sale
9,321 -27.8%
72.25
US$673,442 		9,321 -27.8% 72.25 US$673,442
2022-04-20 2022-04-18
PlS Planned sale
8,941 -29.8%
73.55
US$657,611 		8,941 -29.8% 73.55 US$657,611
2021-06-08 2021-06-07
PlS Planned sale
2,278 -17.8%
60.50
US$137,819 		2,278 -17.8% 60.50 US$137,819
2021-06-08 2021-06-04
S Sale
1,222 -8.7%
61.04
US$74,587 		1,222 -8.7% 61.04 US$74,587
2021-01-08 2021-01-06
PlS Planned sale
110 -0.8%
60.81
US$6,689 		110 -0.8% 60.81 US$6,689
2020-11-17 2020-11-13
PlS Planned sale
21,000 -60.0%
63.51
US$1,333,710 		21,000 -60.0% 63.51 US$1,333,710
2020-11-17 2020-11-13
PlS Planned sale
4,000 -10.3%
62.67
US$250,680 		4,000 -10.3% 62.67 US$250,680
2020-09-21 2020-09-17
PlS Planned sale
2,888 -17.1%
60.26
US$174,031 		2,888 -17.1% 60.26 US$174,031
2020-09-21 2020-09-17
PlS Planned sale
22,532 -57.2%
59.75
US$1,346,287 		22,532 -57.2% 59.75 US$1,346,287